GlassScriptPhysician profile
Crystal Taylor
NPI 1184915753
$2,012.45
in general payments reported to CMS, 2019-2025
28 companies · $690 in 2025
The $690 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $65.74 · 2021: $36.25 · 2022: $149 · 2023: $301 · 2024: $499 · 2025: $690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,404 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,404.49 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $385.10 | 2019-2023 | Lo Loestrin Fe, Orilissa, Ubrelvy |
| Biogen, INC. | $318.86 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $223.24 | 2023-2025 | Veozah |
| Organon LLC | $149.68 | 2022-2025 | Nexplanon |
| Shield Therapeutics INC | $116.69 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $111.97 | 2023-2025 | Myfembree |
| Baxter Healthcare | $94.75 | 2025 | Perclot |
| Pfizer INC. | $66.05 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.11 | 2022-2025 | |
| Exeltis, USA INC. | $50.32 | 2022-2024 | Slynd |
| Mayne Pharma Commercial LLC | $42.69 | 2025 | |
| Millicent US INC | $40.38 | 2024-2025 | Femring, Intrarosa, Femlyv |
| Pharmacosmos Therapeutics INC. | $37.79 | 2024 | Monoferric |
| Medtronic, INC. | $35.31 | 2023 | Ligasure, Truclear |
| Dexcom, INC. | $35.07 | 2025 | Dexcom G6 Transmitter |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $30.08 | 2022-2024 | Twirla |
| Minerva Surgical, INC | $28.66 | 2019-2022 | |
| Applied Medical Resources Corporation | $27.41 | 2024 | |
| Novo Nordisk INC | $21.67 | 2023 | Wegovy |
| Monaghan Medical Corporation | $21.67 | 2023 | Aerochamber |
| Takeda Pharmaceuticals U.S.A., INC. | $19.50 | 2023 | |
| Allergan, INC. | $18.45 | 2019 | |
| Hologic Sales and Service, LLC | $16.71 | 2024 | Thinprep 2000 Processor, Aptima |
| Covidien LP | $15.62 | 2020 | |
| Amag Pharmaceuticals, INC. | $14.58 | 2019 | |
| Avion Pharmaceuticals | $13.55 | 2021 | |
| Merck Sharp & Dohme LLC | $12.35 | 2019 | |
| Therapeuticsmd, INC. | $11.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.